New Stock News | Shenzhen Mindray Bio-Medical Electronics (300760.SZ) has appointed Huatai and Morgan Stanley to handle its Hong Kong listing work.

According to reports, Chinese medical equipment manufacturer Shenzhen Mindray Bio-Medical Electronics (300760.SZ) plans to have a secondary listing in Hong Kong, with expectations to raise at least $1 billion USD, and the stock issuance is being prepared by Huatai and J.P. Morgan. It is reported that more banks may be involved in the listing process in the future. Both Huatai and J.P. Morgan have declined to comment; Shenzhen Mindray Bio-Medical Electronics has not responded yet. As a leading global medical equipment and solutions provider, Shenzhen Mindray Bio-Medical Electronics has the most comprehensive product line in the industry in China. Its products such as monitors, anesthesia machines, ventilators, defibrillators, hematology analyzers, ultrasound machines, etc., are among the top three in the global market share. The company's medical ecosystem continues to deepen in the clinical setting, focusing on critical care departments. In 2024, it launched the Yuanyuan Critical Care Large Model, which is expected to be applied in emergency, anesthesia, imaging, laboratory and other departments in the future, expanding the application of digital intelligence in areas such as auxiliary diagnosis and treatment, report generation and review, clinical case and knowledge retrieval, teaching and research, among others.